We have observed
2 EP applications
Stephanie Joan Pilkington
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after June 30, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
USE OF ADENOSINE RECEPTOR SIGNALING TO MODULATE PERMEABILITY OF BLOOD-BRAIN BARRIER
AN ANTIMICROBIAL COMPOSITION